Kaavya M. is a seasoned professional in Regulatory Affairs, currently serving as the Director of Regulatory Affairs CMC at Eli Lilly and Company since 2025. Previously, Kaavya held the position of Director of Regulatory Affairs CMC at Prevail Therapeutics from 2021 to 2024 and has extensive experience in the field, including roles at Bayer and Dr. Reddy's Laboratories. Kaavya completed a Bachelor of Science at Jawaharlal Nehru Technological University and earned multiple master's degrees, including from Murray State University and the University of Southern California.
This person is not in the org chart
This person is not in any teams
This person is not in any offices